Transdermal Drug Delivery Devices Market 20262031

November 2025 | 223 pages | ID: TBDEBF202E11EN
DataM Intelligence

Abstracts

The Transdermal Drug Delivery Devices Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.095 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Transdermal Drug Delivery Devices Market.

This report delivers a comprehensive overview of the Transdermal Drug Delivery Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transdermal Drug Delivery Devices Market. The Transdermal Drug Delivery Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –2031.

Transdermal Drug Delivery Devices Market Scope:

By Product Type

• Reservoir Patch
• Matrix Patch
• Drug-in Adhesive Patch
• Micro-needle Patch

By Technology

• Passive Transdermal Technology
• Active Transdermal Technology

By Application

• Pain Management
• Hormone Replacement Therapy
• Contraception
• Neurological Disorders
• Smoking Cessation
• Cardiovascular Disorders
• Diabetes
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Homecare Setting

Key Players

• Novartis
• Zydus Lifesciences Ltd
• Boehinger Ingelheim International GmbH
• AbbVie (Allergan)
• UCB S.A.
• Viatris Inc.
• Noven Pharmaceuticals, Inc.
• Acrux Limited
• Purdue Pharma L.P.
• Endo International plc(LIST NOT EXHAUSTIVE)

Major Highlights

This report delivers a comprehensive overview of the Transdermal Drug Delivery Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transdermal Drug Delivery Devices Market. The Transdermal Drug Delivery Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Expanding areas of application of transdermal drug delivery systems
    4.1.1.2. Surge in novel product launches
    4.1.1.3. Increasing incidence of infectious diseases
  4.1.2. Restraints:
    4.1.2.1. Limitations associated with transdermal drug delivery devices
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Reservoir Patch *
  7.2.1. Introduction
  7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Matrix Patch
7.4. Drug-in Adhesive Patch
7.5. Micro-needle Patch

8. BY TECHNOLOGY

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  8.1.2. Market Attractiveness Index, By Technology
8.2. Passive Transdermal Technology *
  8.2.1. Introduction
  8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  8.2.3. Chemical Enhancers
  8.2.4. Prodrug
  8.2.5. Eutectic Systems
8.3. Active Transdermal Technology
  8.3.1. Radiofrequency Ablation
  8.3.2. Laser Thermal Ablation
  8.3.3. Electroporation
  8.3.4. Iontophoresis
  8.3.5. Microneedle
  8.3.6. Jet Injector
  8.3.7. Ultrasound

9. BY APPLICATION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.1.2. Market Attractiveness Index, By Application
9.2. Pain Management *
  9.2.1. Introduction
  9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Hormone Replacement Therapy
9.4. Contraception
9.5. Neurological Disorders
9.6. Smoking Cessation
9.7. Cardiovascular Disorders
9.8. Diabetes
9.9. Others

10. BY END-USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
  10.2.1. Introduction
  10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgical Centers
10.4. Homecare Setting

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. U.K.
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Products Benchmarking
12.4. List of Key Companies to Watch

13. COMPANY PROFILES

13.1. Novartis *
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Zydus Lifesciences Ltd
13.3. Boehinger Ingelheim International GmbH
13.4. AbbVie (Allergan)
13.5. UCB S.A.
13.6. Viatris Inc.
13.7. Noven Pharmaceuticals, Inc.
13.8. Acrux Limited
13.9. Purdue Pharma L.P.
13.10. Endo International plc(*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and End-User
14.3. Contact Us